Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2024, Cilt: 3 Sayı: 1, 161 - 166, 25.04.2024

Öz

Kaynakça

  • Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol rev., 2000;80(3):1107-213.
  • Ohtsuki S, Tachikawa M, Takanaga H, Shimizu H, Watanabe M, Hosoya K, et al. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab., 2002;22(11):1327-35.
  • Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta., 1992;1102(2):119-66.
  • Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids., 2011;40(5):1271-96.
  • Brosnan JT, Brosnan ME. Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu rev Nutr., 2007;27:241-61.
  • Stockler-Ipsiroglu S, Apatean D, Battini R, DeBrosse S, Dessoffy K, Edvardson S, et al. Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide. Mol Genet Metab., 2015;116(4):252-9.
  • Item CB, Stöckler-Ipsiroglu S, StrombergerC, Mühl A, Alessandrì MG, Bianchi MC, et al Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am j Hum Genet., 2001;69(5):1127-33.
  • Verhoeven NM, schor Ds, Roos B, Battini R, Stöckler-Ipsiroglu S, Salomons GS, et al Diagnostic enzyme assay that uses stableisotope-labeled substrates to detect larginine:glycine amidinotransferase deficiency. Clin Chem., 2003;49(5):803-5.
  • Mercimek-Andrews S, Salomons GS. Creatine Deficiency Disorders. 2009 Jan 15 [updated 2022 Feb 10]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean Li H, Gripp KW, et al, eds. Genereviews® [Internet]. Seattle (WA): university of Washington, Seattle; 1993-2023.
  • Mulik C, Mercimek-Andrews S. Creatine Deficiency Disorders: Phenotypes, Genotypes, Diagnosis, and Treatment outcomes. Turk Arch Pediatr., 2023;58(2):129-35.
  • Buchberger W, Ferdig M. Improved highperformance liquid chromatographic determination of guanidino compounds by precolumn derivatization with ninhydrin and fluorescence detection. J Sep Sci., 2004 Nov;27(15-16):1309-12.
  • Benoit R, Samir M, Boutin J, Samuel A, Brigitte C, Dominique D, Isabelle RV. LCMS/MS measurements of urinary guanidinoacetic acid and creatine: Method optimization by deleting derivatization step. Clin Chim Acta., 2019 Jun;493:148-155.
  • Valongo C, Cardoso ML, Domingues P, Almeida L, Verhoeven N, Salomons G, Jakobs C, Vilarinho L. Age related reference values for urine creatine and guanidinoacetic acid concentration in children and adolescents by gas chromatography-mass spectrometry. Clin Chim Acta., 2004 Oct;348(1-2):155-61.
  • Zinellu A, Sotgia S, Zinellu E, Chessa R, Deiana L, Carru C. Assay for the simultaneous determination of guanidinoacetic acid, creatinine and creatine in plasma and urine by capillary electrophoresis UV-detection. J Sep Sci., 2006 Mar;29(5):704-8.
  • EURACHEM Guide 1998. The fitness for purpose of analytical methods: A laboratory guide to method validation and related topics. Available at http://eurachem.org/

Determination of Guanidinoacetic Acid in Urine by HPLC-FLD Method

Yıl 2024, Cilt: 3 Sayı: 1, 161 - 166, 25.04.2024

Öz

Creatine deficiency syndromes are newly recognized inherited metabolic disorders. Creatine is classified into three groups according to the synthesis steps: guanidinoacetate N-methyl transferase (GAMT) deficiency, arginine-glycine amidinotransferase (AGAT) deficiency, and creatine transporter disorder. Clinically, mental retardation, speech delay, epilepsy, movement, and behavioral disorders are prominent. The common biochemical finding in all three diseases is cerebral creatine deficiency. Low urinary guanidinoacetate (GAA) levels are observed in AGAT deficiency and high urinary GAA levels are observed in GAMT deficiency. In this study, we developed a new, simple, inexpensive, and rapid chromatographic analysis method for the quantitative determination of guanidinoacetate in urine samples. Guanidinoacetate was chromatographically separated with a buffer containing 50 mM formic acid and methanol, 1.0 mL/min flow, C18 (150 mm 4.6 mm, 5.0 µm) analytical column and fluorescence detector at ƛex: 390 nm, ƛem: 470 nm.

Etik Beyan

Ethics commitee approval of not required in this study

Destekleyen Kurum

No

Kaynakça

  • Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol rev., 2000;80(3):1107-213.
  • Ohtsuki S, Tachikawa M, Takanaga H, Shimizu H, Watanabe M, Hosoya K, et al. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab., 2002;22(11):1327-35.
  • Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta., 1992;1102(2):119-66.
  • Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids., 2011;40(5):1271-96.
  • Brosnan JT, Brosnan ME. Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu rev Nutr., 2007;27:241-61.
  • Stockler-Ipsiroglu S, Apatean D, Battini R, DeBrosse S, Dessoffy K, Edvardson S, et al. Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide. Mol Genet Metab., 2015;116(4):252-9.
  • Item CB, Stöckler-Ipsiroglu S, StrombergerC, Mühl A, Alessandrì MG, Bianchi MC, et al Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am j Hum Genet., 2001;69(5):1127-33.
  • Verhoeven NM, schor Ds, Roos B, Battini R, Stöckler-Ipsiroglu S, Salomons GS, et al Diagnostic enzyme assay that uses stableisotope-labeled substrates to detect larginine:glycine amidinotransferase deficiency. Clin Chem., 2003;49(5):803-5.
  • Mercimek-Andrews S, Salomons GS. Creatine Deficiency Disorders. 2009 Jan 15 [updated 2022 Feb 10]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean Li H, Gripp KW, et al, eds. Genereviews® [Internet]. Seattle (WA): university of Washington, Seattle; 1993-2023.
  • Mulik C, Mercimek-Andrews S. Creatine Deficiency Disorders: Phenotypes, Genotypes, Diagnosis, and Treatment outcomes. Turk Arch Pediatr., 2023;58(2):129-35.
  • Buchberger W, Ferdig M. Improved highperformance liquid chromatographic determination of guanidino compounds by precolumn derivatization with ninhydrin and fluorescence detection. J Sep Sci., 2004 Nov;27(15-16):1309-12.
  • Benoit R, Samir M, Boutin J, Samuel A, Brigitte C, Dominique D, Isabelle RV. LCMS/MS measurements of urinary guanidinoacetic acid and creatine: Method optimization by deleting derivatization step. Clin Chim Acta., 2019 Jun;493:148-155.
  • Valongo C, Cardoso ML, Domingues P, Almeida L, Verhoeven N, Salomons G, Jakobs C, Vilarinho L. Age related reference values for urine creatine and guanidinoacetic acid concentration in children and adolescents by gas chromatography-mass spectrometry. Clin Chim Acta., 2004 Oct;348(1-2):155-61.
  • Zinellu A, Sotgia S, Zinellu E, Chessa R, Deiana L, Carru C. Assay for the simultaneous determination of guanidinoacetic acid, creatinine and creatine in plasma and urine by capillary electrophoresis UV-detection. J Sep Sci., 2006 Mar;29(5):704-8.
  • EURACHEM Guide 1998. The fitness for purpose of analytical methods: A laboratory guide to method validation and related topics. Available at http://eurachem.org/
Toplam 15 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Kimya
Bölüm Research Articles
Yazarlar

Mehmet Şerif Cansever 0000-0003-3315-5124

Esra İşat Bu kişi benim 0000-0001-7487-1376

Yayımlanma Tarihi 25 Nisan 2024
Gönderilme Tarihi 7 Mart 2024
Kabul Tarihi 3 Nisan 2024
Yayımlandığı Sayı Yıl 2024 Cilt: 3 Sayı: 1

Kaynak Göster

EndNote Cansever MŞ, İşat E (01 Nisan 2024) Determination of Guanidinoacetic Acid in Urine by HPLC-FLD Method. Anatolian Journal of Pharmaceutical Sciences 3 1 161–166.

by.png

This work is licensed by CC by under the Creative Commons Attribution 4.0 International License.